This review succinctly discusses the unique relationship between PPARα nuclear action and lysosomal activity and explores its impact on hepatic lipid homeostasis under pathological conditions such as non-alcoholic fatty liver disease (NAFLD). The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatotic liver disease.